Content
All Posts > Content under Pharma/Biotech
Money Monday
Article By:
Vivian Lewis
Read
Monday, August 3, 2020 6:25 PM EDT
Today, after the pileup of results last week, markets caught their breath and rose. We had good news from a Japanese favorite, bad news from a British bank we sold, and good news for a Chinese firm.The Dow is up too.
Street Missing 'Eye-Catching' CymaBay Data, Says Piper Sandler
Article By:
The Fly
Read
Monday, August 3, 2020 1:36 PM EDT
August 3's topline data from CymaBay's halted Phase 3 study answered key questions for seladelpar around its effect on itch, a hallmark symptom of primary biliary cholangitis, Piper Sandler analyst Yasmeen Rahimi tells investors in a research note.
In this article: CBAY
Bristol-Myers Squibb: A Pipeline To Profits
Article By:
MoneyShow.com
Read
Sunday, August 2, 2020 10:11 AM EDT
The most important question you can ask about the typical big drugmaker is whether its pipeline will support outsized growth in the future; at Bristol-Myers Squibb, the answer seems to be yes.
In this article: BMY
Biotech IPOs In The Time Of Coronavirus
Article By:
Michael A. Robinson
Read
Sunday, August 2, 2020 7:10 AM EDT
With COVID-19 dominating the news cycle, it is no wonder that biotech is front and center in people’s minds. Almost every day, news from companies like Moderna Inc., Gilead Sciences Inc., Sorrento Therapeutics Inc., are making the headlines.
A Summer Road Trip
Article By:
Michele Schneider
Read
Sunday, August 2, 2020 2:39 AM EDT
Besides remaining extremely bullish on gold and silver, the junk bonds and Economic Modern Family continue to serve as our best guide for market price-which in the end, is the only thing that matters.
In this article: QQQ, AAPL, AMZN, DIA, IWM, IYT, JNK, KRE, LQD, SMH, SPY, VXX, XRT, META, GOOGL, IBB, GILD, GLD
With Legalization On The Horizon The U.S. Cannabis Sector Is Setting The Stage To Emerge As The Global Cannabis Leader
Article By:
Technical420
Read
Saturday, August 1, 2020 10:52 PM EDT
During the last year, we have noticed a paradigm shift in the cannabis industry and have watched as US cannabis companies have started to put up stronger numbers than leading Canadian cannabis producers.
FTSE 100 Pushing Down On Support As GBP/USD Strength Weighs
Week In Review: Shanghai Hansoh Enters $68 Million Deal For Leukemia Candidate
Article By:
ChinaBio® Today
Read
Saturday, August 1, 2020 1:34 PM EDT
Shanghai Hansoh Pharma obtained Greater China rights to a BCR-ABL inhibitor discovered by Terns Pharma of California. Hansoh will make an upfront payment, plus milestones of up to $68 million. It will also pay royalties on sales.
Markets Up On Split News
Article By:
Vivian Lewis
Read
Friday, July 31, 2020 8:31 PM EDT
Apple is doing a 4:1 split which will have nil impact on its valuation, but hopes that Amazon and Google and perhaps Facebook will do the same their shares on Wall Street. The Dow is down but would be down more if not for hopes of the splits.